{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:45:18Z","timestamp":1785660318163,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["SAC160073"],"award-info":[{"award-number":["SAC160073"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["CCR14300865"],"award-info":[{"award-number":["CCR14300865"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["SAC150021"],"award-info":[{"award-number":["SAC150021"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"crossref","award":["P30CA047904"],"award-info":[{"award-number":["P30CA047904"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA180921"],"award-info":[{"award-number":["U24CA180921"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Breast cancer is the most common malignancy to spread to the orbit and periorbit, and the invasive lobular carcinoma (ILC) histologic subtype of breast cancer has been reported to form these ophthalmic metastases (OM) more frequently than invasive ductal carcinomas (IDC). We herein report our single academic institution experience with breast cancer OM with respect to anatomical presentation, histology (lobular vs. ductal), treatment, and survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We employed the natural language processing platform, TIES (Text Information Extraction System), to search 2.3 million de-identified patient pathology and radiology records at our institution in order to identify patients with OM secondary to breast cancer. We then compared the resultant cohort, the \u201cOM cohort,\u201d to two other representative metastatic breast cancer patient (MBC) databases from our institution. Histological analysis of selected patients was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our TIES search and manual refinement ultimately identified 28 patients who were diagnosed with breast cancer between 1995 and 2016 that subsequently developed OM. Median age at diagnosis was 54 (range 28\u201377) years of age. ER, PR, and HER2 status from the 28 patients with OM did not differ from other patients with MBC from our institution. The relative proportion of patients with ILC was significantly higher in the OM cohort (32.1%) than in other MBC patients in our institution (11.3%,<jats:italic>p<\/jats:italic>\u2009=\u20090.007). Median time to first OM in the OM cohort was 46.7\u2009months, and OM were the second most frequent first metastases after bony metastases. After diagnosis of the first distant metastasis of any kind, median survival of patients with ILC (21.4\u2009months) was significantly shorter than that of patients with IDC (55.3\u2009months,<jats:italic>p<\/jats:italic>\u2009=\u20090.03). Nine patients developed bilateral OM. We observed a significant co-occurrence of OM and central nervous system metastases (<jats:italic>p<\/jats:italic>\u2009=\u20090.0053). The histological analysis revealed an interesting case in which the primary tumor was of a mixed ILC\/IDC subtype, while only ILC was present in the OM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>OM from breast cancer are illustrative of the difference in metastatic behavior of ILC versus IDC and should be considered when treating patients with ILC, especially in those with complaints of visual acuity changes.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13058-020-01309-3","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T02:02:43Z","timestamp":1593136963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology"],"prefix":"10.1186","volume":"22","author":[{"given":"Martin","family":"Blohmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Brufsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Jankowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"S3","key":"1309_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","volume":"17","author":"M Ghoncheh","year":"2016","unstructured":"Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17(S3):43\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1309_CR2","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","volume":"289","author":"C Li","year":"2003","unstructured":"Li C, Anderson B, Daling J, Moe R. Trends in incidence rates of invasive lobular and ductal breast carcinoma. J Am Med Assoc. 2003;289:1421\u20134.","journal-title":"J Am Med Assoc"},{"issue":"1","key":"1309_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","volume":"17","author":"AE McCart Reed","year":"2015","unstructured":"McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res. 2015;17(1):12.","journal-title":"Breast Cancer Res"},{"key":"1309_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.semdp.2009.12.009","volume":"27","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Ellis IO. Lobular breast carcinoma and its variants. Semin Diagn Pathol. 2010;27:49\u201361.","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"1309_CR5","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6(3):R149\u201356.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"1309_CR6","doi-asserted-by":"publisher","first-page":"e0182397","DOI":"10.1371\/journal.pone.0182397","volume":"12","author":"Z Chen","year":"2017","unstructured":"Chen Z, Yang J, Li S, Lv M, Shen Y, Wanf B, et al. Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma. PLoS One. 2017;12(9):e0182397.","journal-title":"PLoS One"},{"issue":"8","key":"1309_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/annonc\/mdl114","volume":"17","author":"M Tubiana-Hulin","year":"2006","unstructured":"Tubiana-Hulin M, Stevens D, Lasry S, Guinebreti\u00e8re JM, Bouita L, Cohen-Solal C, et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol. 2006;17(8):1228\u201333.","journal-title":"Ann Oncol"},{"issue":"25","key":"1309_CR8","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","volume":"33","author":"FO Metzger","year":"2015","unstructured":"Metzger FO, Giobbie-Hurder A, Mallon E, Gusterson B, Viale G, Winer EP, et al. Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial. J Clin Oncol. 2015;33(25):2772\u20139.","journal-title":"J Clin Oncol"},{"key":"1309_CR9","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","volume":"26","author":"BC Pestalozzi","year":"2008","unstructured":"Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26:3006\u201314.","journal-title":"J Clin Oncol"},{"key":"1309_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1055\/s-0043-109374","volume":"77","author":"A Mathew","year":"2017","unstructured":"Mathew A, Rajapogal P, Villgran V, Sandhu G, Jankowitz R, Jacob M, et al. Distinct pattern of metastases in patients with invasive lobular carcinoma of the breast. Geburtshilfe Frauenheilkd. 2017;77:660\u20136.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"1309_CR11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2214\/AJR.13.11156","volume":"202","author":"H He","year":"2014","unstructured":"He H, Gonzalez A, Robinson E, Yang WT. Distant metastatic disease manifestations in infiltrating lobular carcinoma of the breast. AJR Am J Roentgenol. 2014;202(5):1140\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1309_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12282-017-0753-4","volume":"24","author":"M Inoue","year":"2017","unstructured":"Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, et al. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer. 2017;24(5):667\u201372.","journal-title":"Breast Cancer"},{"issue":"4","key":"1309_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/archopht.1974.01010010286003","volume":"92","author":"A Ferry","year":"1974","unstructured":"Ferry A, Font R. Carcinoma metastatic to the eye and orbit I. a clinicopathologic study of 227 cases. Arch Ophthalmol. 1974;92(4):276\u201386.","journal-title":"Arch Ophthalmol"},{"key":"1309_CR14","doi-asserted-by":"crossref","unstructured":"Wladis EJ, Lee KW, Nazeer T. Metastases of systemic malignancies to the orbit: a major review [published online ahead of print, 2020 Apr 27]. Orbit. 2020:1\u20135.","DOI":"10.1080\/01676830.2020.1759110"},{"key":"1309_CR15","doi-asserted-by":"publisher","first-page":"574086","DOI":"10.1155\/2015\/574086","volume":"2015","author":"I Georgalas","year":"2015","unstructured":"Georgalas I, Paraskevopoulos T, Koutsandrea C, Kardara E, Malamos P, Ladas D, et al. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015:574086.","journal-title":"Biomed Res Int"},{"issue":"6","key":"1309_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/ceo.12926","volume":"45","author":"N Homer","year":"2017","unstructured":"Homer N, Jakobiec FA, Stagner A, Cunnane ME, Freitag SK, Fay A, et al. Periocular breast carcinoma metastases: correlation of clinical, radiologic and histopathologic features. Clin Exp Ophthalmol. 2017;45(6):606\u201312.","journal-title":"Clin Exp Ophthalmol"},{"key":"1309_CR17","first-page":"1","volume":"1","author":"IM Tsagkaraki","year":"2019","unstructured":"Tsagkaraki IM, Kourouniotis CD, Gomatou GL, Syrigos NK, Kotteas EA. Orbital metastases of invasive lobular breast carcinoma. Breast Dis. 2019;1:1\u20137.","journal-title":"Breast Dis"},{"issue":"1","key":"1309_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/cam4.331","volume":"4","author":"M Raap","year":"2014","unstructured":"Raap M, Antonopoulos W, D\u00e4mmrich M, Christgen H, Steinmann D, L\u00e4nger F, et al. High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med. 2014;4(1):104\u201311.","journal-title":"Cancer Med"},{"key":"1309_CR19","doi-asserted-by":"crossref","unstructured":"Nifos\u00ed G, Zuccarello M. Unilateral localized extraocular muscle metastasis by lobular breast carcinoma. BMJ Case Rep. 2018;2018:bcr-2018\u2013224726.","DOI":"10.1136\/bcr-2018-224726"},{"issue":"5","key":"1309_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/IOP.0000000000000793","volume":"33","author":"FA Jakobiec","year":"2017","unstructured":"Jakobiec FA, Stagner AM, Homer N, Yoon MK. Periocular breast carcinoma metastases: predominant origin from the lobular variant. Ophthalmic Plast Reconstr Surg. 2017;33(5):361\u20136.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1309_CR21","unstructured":"Text Information Extraction System (TIES) Software. Available from: http:\/\/www.ties.dbmi.pitt.edu\/. Accessed 6 Jan 2020."},{"issue":"24","key":"1309_CR22","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-15-1973","volume":"75","author":"RS Jacobson","year":"2015","unstructured":"Jacobson RS, Becich MJ, Bollag RJ, Chavan G, Corrigan J, Dhir R, et al. A federated network for translational cancer research using clinical data and biospecimens. Cancer Res. 2015;75(24):5194\u2013201.","journal-title":"Cancer Res"},{"key":"1309_CR23","unstructured":"Vector realistic human eye cross section side view close up isolated on white baclground [sic]. Available from: https:\/\/www.shutterstock.com\/image-vector\/vector-realistic-human-eye-cross-section-1298160145. Accessed 6 Jan 2020."},{"issue":"2","key":"1309_CR24","first-page":"1","volume":"37","author":"A Maheshwari","year":"2018","unstructured":"Maheshwari A, Finger PT. Cancers of the eye. Cancer Metastasis. 2018;37(2):1\u201314.","journal-title":"Cancer Metastasis"},{"issue":"5","key":"1309_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00002341-200109000-00009","volume":"17","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle RC. Cancer metastatic to the orbit. Ophthalmic Plast Reconstr Surg. 2001;17(5):346\u201354.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1309_CR26","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1167\/iovs.16-19695","volume":"57","author":"R Parrozzani","year":"2016","unstructured":"Parrozzani R, Frizziero L, Testi I, Miglionico G, Perrini P, Pulze S, et al. Intraocular metastases secondary to breast carcinoma correlates with upregulation of estrogen and progesterone receptor expression in the primary tumor. Invest Ophthalmol Vis Sci. 2016;57:3944\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1309_CR27","doi-asserted-by":"crossref","unstructured":"Sindoni A, Fama' F, Vinciguerra P, Dionigi G, Manara S, Gioffre\u2019-Florio M, et al. Orbital metastases from breast cancer: A single institution case series [published online ahead of print, 2020 Apr 15]. J Surg Oncol 2020;10.1002.","DOI":"10.1002\/jso.25927"},{"issue":"4","key":"1309_CR28","first-page":"284","volume":"19","author":"T Nowikiewicz","year":"2015","unstructured":"Nowikiewicz T, Wi\u015bniewska M, Wi\u015bniewski M, Biedka M, G\u0142owacka I, Kozak D, et al. Overall survival and disease-free survival in breast cancer patients treated at the Oncology Centre in Bydgoszcz - analysis of more than six years of follow-up. Contemp Oncol (Pozn). 2015;19(4):284\u20139.","journal-title":"Contemp Oncol (Pozn)"},{"key":"1309_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7525-7-18","volume":"7","author":"RM van Nispen","year":"2009","unstructured":"van Nispen RM, de Boer MR, Hoeijmakers JG, Ringens PJ, van Rens GH. Co-morbidity and visual acuity are risk factors for health-related quality of life decline: five-month follow-up EQ-5D data of visually impaired older patients. Health Qual Life Outcomes. 2009;7:18.","journal-title":"Health Qual Life Outcomes"},{"key":"1309_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12885-018-5253-1","volume":"19","author":"M Framarino-Dei-Malatesta","year":"2019","unstructured":"Framarino-Dei-Malatesta M, Chiarito A, Bianciardi F, Fiorelli M, Ligato A, Naso G, et al. Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature. BMC Cancer. 2019;19:36.","journal-title":"BMC Cancer"},{"issue":"10","key":"1309_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/bjo.82.10.1159","volume":"82","author":"T Wiegel","year":"1998","unstructured":"Wiegel T, Kreusel KM, Bornfeld N, Bottke D, Stange M, Foerster MH, et al. Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme. Br J Ophthalmol. 1998;82(10):1159\u201361.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1309_CR32","first-page":"1906","volume":"40","author":"SB Ogueta","year":"1999","unstructured":"Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci. 1999;40(9):1906\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1309_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/02713683.2014.935446","volume":"40","author":"CM Colitz","year":"2015","unstructured":"Colitz CM, Lu P, Sugimoto Y, Barden CA, Chandler HL. Estradiol biosynthesis in canine lens epithelial cells. Curr Eye Res. 2015;40(5):541\u20138.","journal-title":"Curr Eye Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-020-01309-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01309-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T11:36:47Z","timestamp":1667129807000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-020-01309-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1186\/s13058-020-01309-3","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}